
Company Info
Phone(561) 989-5800
Year Established
2004
Ticker
ADMA
Exchange
NASDAQ
Contacts
Adam S. GrossmanFounder, President, CEO & Interim CFO
Drew Pantello
VP, Marketing & Corporate Development
Company Description
ADMA Biologics is an end-to-end biopharmaceutical company with three FDA-licensed approved products including ASCENIV (Immune Globulin Intravenous - slra, Human), BIVIGAMᆴ (Immune Globulin Intravenous, Human), and NABI-HB (hepatitis B immune globulin, human).